U.S. BioDefense Signs Agreement to Evaluate and Option to License Adult Stem Cell Sorting and Enrichment Patent Rights Applications Related to Gene Therapy and Bioengineered Skin Process Now in FDA Proof of Concept Developed in Part by A $1.25 Million Grant From The National Institute of Dental and Craniofacial Research, Part of The National Institutes of Health
25 janv. 2005 08h30 HE
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Jan. 25, 2005 (PRIMEZONE) -- U.S. BioDefense (OTCBB:UBDF) is pleased to announce today that it has signed an option license agreement with a major university and will now...
U.S. BioDefense to Launch Open Source Platform for Rapid Stem Cell Research and Development
21 janv. 2005 07h45 HE
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Jan. 21, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDF) announced today that it is developing an Open Source Stem Cell Research Platform to leverage the distributed...
U.S. BioDefense Files 'Stem Cell Technology and Autologous Bioengineered Skin for Medical Countermeasure' Proposal with Department of Defense Chemical Biological Defense Agency
18 janv. 2005 09h00 HE
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Jan. 18, 2005 (PRIMEZONE) -- U.S. BioDefense (OTCBB:UBDF) is pleased to announce that it has met today's deadline to file its Small Business Innovation Research (SBIR) Grant...